Forte Biosciences
FBRX
FBRX
57 hedge funds and large institutions have $65.6M invested in Forte Biosciences in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
22% less call options, than puts
Call options by funds: $331K | Put options by funds: $425K
27% less capital invested
Capital invested by funds: $90.3M → $65.6M (-$24.7M)
Holders
57
Holding in Top 10
–
Calls
$331K
Puts
$425K
Top Buyers
| 1 | +$2.93M | |
| 2 | +$2.17M | |
| 3 | +$1.02M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.02M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$942K |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$5.19M | |
| 3 | -$3.13M | |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$1.48M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$950K |